Lorus Therapeutics Inc.    

 
TORONTO: LOR

Address:

2 Meridian Rd.

Toronto, ON M9W 4Z7

Canada

Phone:
(416) 798-1200

Fax:
(416) 798-2200


Company description

Manufacturing: Pharmaceutical company focused on the development of cancer therapies.

Log in for comprehensive information about this and hundreds of thousands of other companies.

News and information about Lorus Therapeutics Inc.

US Patent Issued to LORUS THERAPEUTICS on April 12 for "2-Substituted Imidazo[4,5-Dphenanthroline Derivatives and Their Use in the Treatment of Cancer" (Canadian Inventor)
US Fed News Service, Including US State News; April 14, 2016; 366 words
...ALEXANDRIA, Va., April 14 -- United States Patent no. 9,309,247, issued on April 12, was assigned to LORUS THERAPEUTICS INC. (Canada)."2-substituted imidazo[4,5-Dphenanthroline derivatives and their use in the treatment...
Wipo Publishes Patent of Lorus Therapeutics for "2-Substituted Imidazo[4,5-D]phenanthroline Derivatives and Their Use in the Treatment of Cancer" (Canadian Inventors)
US Fed News Service, Including US State News; December 3, 2014; 367 words
...SUBSTITUTED IMIDAZO[4,5-D]PHENANTHROLINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER."Applicants: LORUS THERAPEUTICS INC. (CA).Inventors: Yoon Lee (CA), Howard Cukier (CA), Venkata Nedunuri (CA), Robert Peralta (CA...
Lorus Therapeutics Recaps Annual and Special Meeting of Shareholders
Health & Beauty Close-Up; August 25, 2014; 700+ words
Lorus Therapeutics has reported voting results from the Company's annual and special meeting of shareholders held on August 19th in Toronto. In...
Lorus Therapeutics Releases 3Q Fiscal 2014 Results
Health & Beauty Close-Up; April 22, 2014; 700+ words
Lorus Therapeutics Inc. has reported financial results for the three and nine months ended February 28, and provided an update on recent accomplishments...
Public Financing of Biotechnology Companies: Commenced Trading in March 2014
BioWorld Insight; April 7, 2014; 700+ words
...Robert W. Baird & Co.; Canaccord Genuity; JMP Securities; Wells Fargo Securities $245.63 $3,180 Lorus Therapeutics Inc. (Toronto; TSX:LOR)22 3/28/14 3/28/14 50S C$0.50 N/A RBC Capital Markets (lead); Roth...
Week in Review
BioWorld Insight; March 31, 2014; 678 words
...series A funding round. Kolltan Pharmaceuticals Inc. has secured $60 million from a series D financing round. Lorus Therapeutics Inc. filed a preliminary prospectus to raise about $15.4 million in an overnight marketed public offering of common...
IIROC Trade Halt - Lorus Therapeutics Incorporated
Financial News Releases; March 26, 2014; 323 words
...Ontario--(Newsfile Corp. - March 26, 2014) - The following issues have been halted by IIROC: Company: Lorus Therapeutics Incorporated TSX Symbol: LOR (all issues) Reason: Pending News Halt Time (ET) 15:01 IIROC can make...
Public Financing of Biotechnology Companies: Commenced Trading in January 2014
BioWorld Insight; February 10, 2014; 700+ words
...Roth Capital Partners; Brean Capital; Ladenburg Thalmann & Co.; H.C. Wainwright & Co. $100 $1.3B Lorus Therapeutics Inc. (Toronto; TSX:LOR)18 12/6/13 1/9/14 1.9S C$0.55 N/A Clarus Sec. (co-lead); Canaccord...

Search HighBeam Business for more news about Lorus Therapeutics Inc.

Industry information

NAICS codes 
North American Industry Classification System (NAICS) codes are used to classify businesses for the purpose of collecting statistical data related to the U.S. economy. NAICS codes have been assigned to international companies to help organize all companies by type of activity.  

Primary: 325414 - Biological Product (except Diagnostic) Manufacturing

325411 - Medicinal and Botanical Manufacturing


 

SIC codes 
Standard Industrial Classification (SIC) codes classify establishments by their primary type of activity. SIC codes are a U.S. Census Bureau system but can apply to international companies.  

Primary: 2836 - Biological Products, Except Diagnostic Substances industry report

2833 - Medicinal Chemicals and Botanical Products industry report